PRNewsWire - Health

Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
T. Rowe Price Renews Transfer Agent Relationship with SS&C
STRETCH ZONE CELEBRATES GRAND OPENING IN MENTOR, OHIO
Rice Biotech Launch Pad welcomes David Allison to external advisory board